经皮冠状动脉介入治疗现在是无保护左主干冠状动脉狭窄的默认血运重建策略吗？ - Suppr

Suppr

超能文献

Is Percutaneous Coronary Intervention Now the Default Revascularization Strategy for Unprotected Left Main Coronary Artery Stenosis?

作者信息

Mukherjee Debabrata

机构信息

Division of Cardiovascular Medicine Texas Tech University Health Sciences Center El Paso TX.

出版信息

J Am Heart Assoc. 2022 Apr 5;11(7):e025748. doi: 10.1161/JAHA.122.025748. Epub 2022 Mar 30.

DOI:10.1161/JAHA.122.025748

PMID:35352567

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075449/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23aa/9075449/14515961f18a/JAH3-11-e025748-g001.jpg

相似文献

Is Percutaneous Coronary Intervention Now the Default Revascularization Strategy for Unprotected Left Main Coronary Artery Stenosis?

J Am Heart Assoc. 2022 Apr 5;11(7):e025748. doi: 10.1161/JAHA.122.025748. Epub 2022 Mar 30.

Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.

Circ Cardiovasc Interv. 2016 Dec;9(12). doi: 10.1161/CIRCINTERVENTIONS.116.004729.

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

Temporal trends in revascularization strategy and outcomes in left main coronary artery stenosis: data from the ASAN Medical Center-Left MAIN Revascularization registry.

Circ Cardiovasc Interv. 2015 Mar;8(3):e001846. doi: 10.1161/CIRCINTERVENTIONS.114.001846.

Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.

Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):318-327. doi: 10.1016/j.jcin.2015.10.044.

Drug-eluting stents in unprotected left main coronary artery disease.

Expert Rev Cardiovasc Ther. 2014 Nov;12(11):1349-68. doi: 10.1586/14779072.2014.967215.

Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

J Am Coll Cardiol. 2015 May 26;65(20):2198-206. doi: 10.1016/j.jacc.2015.03.033. Epub 2015 Mar 15.

Long-term clinical outcomes after a percutaneous coronary intervention with a drug-eluting stent in patients with unprotected left main coronary artery disease excluded from clinical trials.

Coron Artery Dis. 2019 Jun;30(4):239-248. doi: 10.1097/MCA.0000000000000718.

引用本文的文献

Coronary Intervention Outcomes in Patients with Liver Cirrhosis.

Curr Cardiol Rep. 2025 Jan 4;27(1):2. doi: 10.1007/s11886-024-02163-x.

本文引用的文献

Trends in Clinical Practice and Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery.

J Am Heart Assoc. 2022 Apr 5;11(7):e024040. doi: 10.1161/JAHA.121.024040. Epub 2022 Mar 30.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.

Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease.

J Am Heart Assoc. 2019 Apr 16;8(8):e011279. doi: 10.1161/JAHA.118.011279.

Enhanced outcomes for coronary artery disease obtained by a multidisciplinary heart team approach.

Gen Thorac Cardiovasc Surg. 2019 Oct;67(10):841-848. doi: 10.1007/s11748-019-01108-4. Epub 2019 Mar 15.

Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Narrowing.

Am J Cardiol. 2017 Jun 1;119(11):1746-1752. doi: 10.1016/j.amjcard.2017.03.009. Epub 2017 Mar 15.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.

Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk.

Curr Vasc Pharmacol. 2016;14(5):415-425. doi: 10.2174/1570161114666160722121615.

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.

Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease.

Circulation. 2013 Jun 4;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646. Epub 2013 May 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验